A combination therapy for kras-Driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin

Yifeng Xia, Yi Liang Liu, Yonghua Xie, Wei Zhu, Francisco Guerra, Shen Shen, Narayana Yeddula, Wolfgang Fischer, William Low, Xiaoying Zhou, Yonghui Zhang, Eric Oldfield, Inder M. Verma

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A combination therapy for kras-Driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology